Abstract-A simplified cochlear implant (CI) system would be appropriate for widespread use in developing countries. Here, we describe a CI that we have designed to realize such a concept. The system implements 8 channels of processing and stimulation using the continuous interleaved sampling (CIS) strategy. A generic digital signal processing (DSP) chip is used for the processing, and the filtering functions are performed with a fast Fourier transform (FFT) of a microphone or other input. Data derived from the processing are transmitted through an inductive link using pulse width modulation (PWM) encoding and amplitude shift keying (ASK) modulation. The same link is used in the reverse direction for backward telemetry of electrode and system information. A custom receiver-stimulator chip has been developed that demodulates incoming data using pulse counting and produces charge balanced biphasic pulses at 1000 pulses/s/electrode. This chip is encased in a titanium package that is hermetically sealed using a simple but effective method. A low cost metal-silicon hybrid mold has been developed for fabricating an intracochlear electrode array with 16 ball-shaped stimulating contacts.
I. INTRODUCTION
A cochlear implant (CI) is a device that can provide a sense of sound to people who are deaf or profoundly hearing-impaired. Significant open-set recognition of speech can be achieved with commercially available multichannel CI systems [1] - [3] . Indeed, a majority of users can converse over the telephone for everyday communications.
Although this performance is spectacular, and can enable users to move from a life of dependence to being strong contributors to society, implants are not available to most of the world's deaf and severely hearing impaired people due to the high cost of these systems. The cost of the implant alone, exclusive of the costs for surgery and rehabilitation, is approximately $25,000 USD [4] . This is most unfortunate, as approximately 80% of the world's hearing impaired people live in developing countries, with highly limited healthcare budgets and widespread poverty. These people, with annual household incomes that typically range between $500 and $1000 USD-or their governments-cannot possibly afford the high cost of currently available implant systems.
This problem was the central theme for a conference held at Zheng-Zhou, He-Nan, China, in 1993. A team of five North American experts was invited to participate in the conference. Following the conference and the knowledge gained from discussions with their Chinese colleagues, they proposed a design for a low cost but effective CI system [5] , [6] . This design included a four-channel continuous interleaved sampling (CIS) processor and four independent sets of transmitting and receiving coils connected to a four channel intracochlear electrode array. Such a system does not require an active implant with hermetically packaged electronics and, thus, avoids the high cost of developing and manufacturing the Integrated Circuit (IC) and the packaging required for an active implant. A prototype of the device was built and tested, including tests with implant patients. Speech test scores were high and comparable to the best scores obtainable with any device at the time.
Although this design was promising, the four separate pairs of transmitting and receiving coils were bulky. In addition, voltage waveforms were used for stimulation rather than constant current sources, which are preferred because these sources maintain stimulation levels across changes in electrode impedance, which invariably occur with use of the device. A further weakness of the design in our view was that, without active electronics, there was no possibility for telemetry from the implanted components, including feedback of electrode impedances, integrity of the receiver coils or connections to the stimulating electrodes.
We thought another attempt at designing a simplified implant system was warranted given: 1) the great need for such a device; 2) the weaknesses of a prior design as noted above; 3) the tremendous advances in electronics and in our knowledge about the minimum requirements for a high-performance implant system that have occurred since that earlier design, now more than a decade old. We, therefore, initiated such an effort at the Seoul National University, with the help of two members of the original group of experts who participated in the conference in Zheng-Zhou and who were among the designers of the prior system (authors BSW and SJR).
The purpose of this paper is to describe this novel design. This design utilizes active electronics in an implanted receiverstimulator IC and includes only a single external transmitting coil paired with a single receiving coil. Additionally, it uses 8 channels of processing and stimulation rather than four. Both the external and internal components are much more compact than in the prior design. The new design utilizes modern electronics and was informed by what is now known about the minimal requirements for high performance with CIs.
II. METHODS
The CI system consists of an external speech processor, an implantable unit, and an inductive telemetry link connecting the two. As shown in Fig. 1(a) , the external speech processor consists of an analog preprocessor and digital signal processing (DSP) hardware. The implantable unit in Fig. 1(b) consists of a hermetically packaged receiver-stimulator IC and an intracochlear array of electrodes. The inductive telemetry link consists of circuits and coils for forward transmission of power and data, and backward transmission of indicators of IC and electrode function.
A. Speech Signal Processing
Results from various studies have shown that increasing the number of channels in a CI beyond 4-8 does not produce measurable improvements in speech perception performance [7] - [9] . Thus, an eight channel system was judged as fully sufficient to guarantee a high level of speech perception.
The system described here uses an 8-channel CIS processing strategy [10] . This strategy is the only one that is included in all currently-available implant systems from the three major manufacturers, and it has been shown to be at least as effective as any other strategy now in widespread use. In addition, CIS is relatively simple to implement compared with other strategies.
The microphone and the external transmitting coil are located in the headset, which is connected to the speech processor. The analog preprocessor consists of a high-pass filter to "flatten" the spectrum of incoming speech [10] , a band-pass filter, and an amplifier with automatic gain control. The preprocessor stage receives audio signals from the microphone, or from other audio sources that are connected via an external input socket. The high-pass filter has a single pole at 1.2 kHz and the band-pass filter is a 4th order Butterworth filter with cutoff frequencies of 300 Hz and 8 kHz. The average overall gain of the input stage (which varies with action of the automatic gain controller) is 45 dB.
We note that adopting a commercially available DSP chip is a lower cost option than developing a customized DSP chip. The commercial DSP chip consumes more power than a custom designed one dedicated to the CI, but it offers more flexibility and is vetted as fully reliable through extensive and widespread use. Fig. 2 shows a functional block diagram of the signal processing performed within the DSP hardware. After digitizing the speech signal, the DSP chip performs frequency analysis using a fast Fourier transform (FFT). The chip then computes the average power of each channel by simple summation and averaging, according to predetermined channel-frequency allocation. Bandpasses for the channels are formed by integration across FFT bins. As an alternative to the FFT method, digital filters could have been implemented using an infinite impulse response (IIR) or finite impulse response (FIR) filter with envelope detection. The FFT approach is more efficient, however, as the total number of computations is substantially lower than in the IIR or FIR approaches. The FFT option also offers flexibility because many functions can be implemented by simple arithmetic operations [11] . For example, parameters such as channel-to-frequency allocation, the order of the filter and overlap of bands between neighboring channels, can be easily controlled by simply changing the number of FFT samples to be averaged and their weights.
B. Communication
Pulse width modulation (PWM) encoding and amplitude shift keying (ASK) modulation and demodulation using pulse counting, are used for the telemetry system. Three kinds of bits are encoded as follows: a logical "one" and "zero" are encoded to have a duty cycle of 75% and 25%, respectively, and an "end-of-frame (EOF)" bit has a 50% duty cycle. Such an encoding method allows easier synchronization and decoding because each bit has a uniform rising edge at its beginning. According to this bit coding scheme, every bit has a high state, which is advantageous for uniform radiofrequency (RF) energy transmission.
Each data frame for forward telemetry consists of 15 bits as shown in Fig. 3 . Each frame can contain different types of information for controlling the implant, as illustrated. The first three bits in each frame specify a data mode. The first bit determines whether the frame is for command or stimulation. The next two bits describe the operation as one of the following: duration/stimulation mode, supply voltage check, or impedance check. In sequences of frames, frame-A defines a stimulation mode and a pulse duration Fig. 3(a) , and frame-B defines one of sixteen electrode sites and a pulse amplitude for each stimulating channel Fig. 3(b) . Prior to the first stimulation, frame-A is delivered, and then multiple frame-Bs are sequentially delivered for multichannel stimulation Fig. 3(c) . In frame-A, monopolar and bipoar stimulation modes are encoded to be "00" and "11," respectively, and the pulse duration is set according to the three duration bits. In each frame-B, electrode site number is encoded with four bits and the stimulation level with eight bits.
Stimulation pulses are presented at the rate of 1000/s/electrode, which requires a sustained transmission data rate of 120 kbps or higher, depending on channel select and pulse duration instructions, in addition to pulse amplitude instructions.
For transcutaneous transmission of PWM encoded data, a class-E tuned power amplifier with high transmission efficiency [12] - [14] is used with amplitude shifted keying (ASK) modulation. The carrier frequency is 2.5 MHz. Alternatively frequency shifted keying (FSK) modulation could have been used, but this requires more complicated components such as a voltage controlled oscillator and low-pass filters with high power dissipation [15] - [17] .
For demodulation of the ASK signals, an ordinary envelope detector can be used. However, this method is sensitive to the distance between the two coils. Instead, we count the number of RF cycles for a given burst [18] , which allows easy discrimination among 0, 1, or EOF bits. We found that this method is more reliable and far less sensitive to the coil-to-coil distance than the envelope detection method.
In the back telemetry system, information about electrode impedances and receiver-stimulator status such as supply voltages and communication errors are fed back to the DSP chip using load modulation. To obtain information about electrode impedances, the receiver/stimulator samples the voltage difference between an active electrode and a reference electrode (the remote reference for monopolar stimulation or one of the two electrodes for bipolar stimulation). This sampled voltage is sent to the external speech processor via the back telemetry link. Electrode impedances are calculated in the external processor using this information. A voltage sampled at a node in the implant is converted to a proportional pulse duration, during which the quality factor of the receiver resonant circuit is reduced [19] . This information is then read using the DSP chip. Alternatively, we could have included a separate inductive link for the backward communication using the FSK modulation, but this would have increased the complexity and size of the overall implant system.
C. The Receiver-Stimulator Chip
The specialized functions of the receiver/stimulator preclude the use of a generic chip. A customized chip was, thus, developed according to our system architecture. The block diagram of the chip with its peripheral circuit is shown in Fig. 4 . Power and data are received at an implanted coil. This coil has a small number of turns compared to the external transmitting coil so that the induced voltage can be lower than a few volts. This small voltage is then stepped up using a small transformer, and a regulated supply of power is obtained.
The stimulator consists of a programmable current source and programmable switches. In the circuit shown in Fig. 5 , E1-E16 represent active electrodes in the intracochlear electrode array while R represents the extra-cochlear reference electrode. By controlling the on/off status and duration of the switches, we can easily determine the shape of stimulation pulses and the stimulation mode (monopolar or bipolar). This circuit is designed so that the biphasic pulse is formed by switching from a single set of current sources to ensure charge balance. Passage of any dc current due to the remaining residual charge at the electrodes is precluded with the use of blocking capacitors between the (switched) current source and all electrodes. In addition, all of the active electrodes are grounded between stimulation events, so any residual charge retained in the blocking capacitors can be removed.
D. Hermetic Package
The implanted receiver/stimulator IC needs to be protected from body fluids and mechanical forces. We have developed a titanium (Ti) package, which consists of a biocompatible Ti housing, platinum (Pt) feedthroughs, and a ceramic plate. The feedthroughs connect the electrode array, the reference electrode, and the receiver coil to the receiver-stimulator chip. A ceramic sintering process is used to fix the feedthroughs in the ceramic plate that provides electrical isolation.
Brazing and laser welding techniques are employed to achieve hermetic sealing. A recently developed nano-sized silicon oxide (SiO ) sol-gel sealing method is used to seal the micro-gaps between the feedthroughs and the ceramic plate [20] . In general, SiO can be a good sealant material. However, the melting point of the covalently bonded SiO crystal is over 1700 making it difficult for use as a sealant material. Recent processing developments have demonstrated that the melting point of the SiO can be drastically decreased if it can be made into nano-sized particles and, and with this its use becomes practical.
The reliability of implant systems depends strongly on the integrity and lifetime of the hermetic seal. Indeed, a breach in the seal has been the failure point for many prior implant systems, including prior generations of present devices. We believe that the application of SiO as a sealant will increase the quality and lifetime of the seal compared with other materials and methods.
E. Intracochlear Electrode Array
Flame formed ball contacts have been employed since the early stages of cochlear implantation [21] , [22] . Such electrodes are still used in clinical applications and are chosen for use in this system because they are simpler to fabricate than the foil type contacts used in some current products.
The electrode array is fabricated in two steps. First, ballshaped contacts are formed by melting Pt/iridium (Ir) wires with an oxygen/acetylene mini-torch. Second, the wires with the attached balls are molded in a silicone elastomer "carrier." An electrode fabricated by this method requires minimum process steps and has no connective junctions between wires and stimulating sites which could be potential sites of failure. Thus, the fabrication is simpler, highly reliable and less costly compared with other approaches.
We have further increased the production yield over conventional methods by using a metal-silicon hybrid molding system. This metal-silicon hybrid mold is composed of a metal base which holds a micormachined silicon insert. The silicon insert contains holes to precisely locate Pt/Ir contact balls as shown in Fig. 6 . The silicon insert is very inexpensive and is discarded after each use to maintain high manufacturing precision. This method increases yield in the molding process and can contribute to lower cost because the metal part of the mold does not need to be a high-precision part.
F. Biocompatibility Testing
To verify the biological safety of the implantable unit, a qualitative cytotoxicity test was conducted based on the ISO 10993-5 and the USP 24-NF19 standards in the Clinical Research Institute of Seoul National University Hospital. NCTC-clone 929 from connective tissues of a 100-day-old mouse was subcultured for over 16 h in a multiple well plate. Fetal Bovine Serum, Penicilli-Streptomycin and L-glutamine contained Minimum Essential Medium was used for the culturing media. The tests consisted of three groups; 1) the experimental group treated with eluate of the implantable unit; 2) the negative control group treated with high-density polyethylene (HDPE) ; 3) the positive control group treated with dimethyl sulfoxide (DMSO). After 24 h of treatment, cell reactivity grades were determined for each of the three groups based on the grading criteria described in Table I .
III. RESULTS
Preliminary testing has demonstrated that the system performs as designed. Fig. 7 shows a set of example waveforms at various points in the system. The top trace shows a speech input measured in an output node of the analog preprocessor and the bottom three traces show stimuli for three of the eight channels of processing and stimulation with 4.5 resistive loads connected between active electrode nodes and a reference electrode node, in place of the electrode array. The stimuli are wellbalanced biphasic pulses presented at the rate of 1000/s/electrode. The pulses are interleaved in time across electrodes so that pulses at any one electrode are not coincident with pulses for any other electrode, as specified by the CIS strategy [10] . This is illustrated further in the lower panel of Fig. 7 , which shows with an expanded time scale the segment demarked in the upper panel with the dotted rectangle. The maximum charge unbalance of a stimulation pulse was measured to be approximately 180 pC, which was eliminated with the grounding of all electrodes between stimulation events.
Pulse amplitudes can range from 7.3 to 1.8 mA in 7.3-steps, and pulse duration can be set from 8.3 to 58.1 in 8.3-steps. Our telemetry circuit delivers digital data reliably with a coil-to-coil distance of up to 13 mm, with a transmission bit-error rate of better than 1 10 . The overall current dissipation of the entire system (including all external and internal components) is 105 mA. This corresponds to 17 h of continuous operation using an 1800 mAh lithium-ion rechargeable battery, which would allow a patient to use the device for a full day without recharging. Photographs of the completed external and implanted components are shown in Fig. 8 . The external speech processor has a size of including the 1800 mAh rechargeable battery attached on the back [ Fig. 8(a) ]. The Ti metal package for the implanted receiver-stimulator is designed to be thin and to have a round shape, reducing the stress induced at the skin after implantation. An oval-shaped anchor with a coarse surface is also made on the bottom of the package for stable fixation and osseointegration to the skull.
The helium leak rate of the hermetically sealed part was tested using the methods described under MIL-STD-883E, Method 1014.10. The result of this test is shown in Fig. 9 . Fig. 9 also illustrates micro-gaps surrounding the feedthrough in [Fig. 9 , inset (a)], and the complete filling of these defects with the nonconductive crystallized SiO layer in [Fig. 9, inset (b) ]. The leak rate of the sol-treated part is less than 1 10 sccs (atm. cm /s). The resistance between adjacent feedthroughs exceeds several giga-ohms for all feedthroughs.
A straight array of intracochlear electrodes is shown in Fig. 10 . Sixteen electrodes are used, allowing for up to 16 channels using monopolar stimulation (with reference to a remote electrode in the temporalis muscle or at some other distant site) or up to 8 channels of bipolar stimulation (between adjacent intracochlear electrodes). The present system is designed to stimulate 8 of the 16 electrodes using the monopolar configuration, with one inactive electrode between each adjacent pair of active electrodes. The intracochlear segment of the electrode array inserted into the scala tympani (ST) of the cochlea is tapered from 0.5 mm at the most apical (distant) part to 0.7 mm at the basal part. The distance between adjacent electrode sites is 1.25 mm and the total length of the intracochlear segment is 24.5 mm, which is designed to be inserted 360 into the ST. As depicted in the inset of Fig. 10 , the balls protrude about 130 from the surface of the silicone carrier. The electrode array has an appropriate stiffness for insertion into the ST [23] . The impedance of the electrode-electrolyte interface was measured to be (in phosphate buffered saline, at 1 kHz). Preliminary results of a collaborative temporal bone study at the University of California, San Francisco, using previously developed methods [24] , demonstrated that the electrode array was successfully implanted into the ST of human temporal bones. In this trial electrodes were inserted to a mean depth of 360 without significant trauma [25] .
The result of the cytotoxicity tests of the implantable unit are presented in Table II . The positive control group showed moderate reaction of cells and the negative control group showed no reaction. The observed reactivity of the two control groups confirm that the cytotoxicity test was performed successfully. In the experimental group that was treated with eluate of the implantable unit, no significant cellular response was observed. IV. DISCUSSION The system described in this report was developed in a university environment as an industrial collaboration program with a new startup company. It is also based on an international collaboration with critical assistance from experts in several areas of CI system design. There also have been expert advice and guidance from surgeons and audiologists. These experts donated their invaluable knowledge and time to the effort, with the hope and expectation that such a system will soon help profoundly hearing impaired people in developing countries who have been unable to benefit from CI technology due to its high cost. These were large contributing factors in reducing the cost of development.
We find that the receiver-stimulator chip, the electrode array, and the hermetic package are the three most critical components in the system. The design and manufacturing of these three components are key factors in determining the cost, performance, and reliability of the complete system. Therefore, to control the price and the quality, we developed each of these parts in house. With this approach, technological options can be selected that are simple and incurred lower manufacturing costs whenever these options do not affect performance or reliability.
In the communication between the receiver-stimulator chip and the speech processor, various options in encoding, modulation, and demodulation have been considered. PWM encoding, ASK demodulation, and pulse counting demodulation were selected based on simplicity and low power consumption. One of the advantages of the pulse counting demodulation is the increase in the allowable distance between the transmitting and receiving coils. When compared with the conventional envelope detection method, we observe up to a two-fold increase in the allowable coil-to-coil distance.
The hermetic package is a critical part that can limit the lifetime of the implant and is a principal contributor to its price. Sealing of the micro-gaps between the feedthroughs and the insulating ceramic plate is crucial. Conventionally, this is done using a brazing method where the local application of filler metal is critical. The SiO sol-gel used in our method is a viscous liquid and can be liberally dispensed in the area rather than being applied locally. This makes the process simple and low cost, while producing a truly outstanding seal.
The electrode array should have mechanical properties that minimize the probability of trauma during surgical insertion. In particular, it is crucial that the electrode array have appropriate stiffness [23] , [25] . The temporal bone trials conducted with these electrodes indicate that a relatively soft array may reduce the incidence of trauma because the contact pressure between the electrode array and the cochlear inner wall is reduced [25] . On the other hand, sufficient stiffness is necessary to facilitate the surgical insertion of the array and to avoid kinking during this process. In general, the stiffness of electrode arrays for CIs is determined by metal wires because they have a Young's Modulus that is several thousands times higher than that of the silicone carrier [23] . Therefore, without a specific feature to increase stiffness of the apical electrode, the tip of the array will have very little inherent stiffness, as the number of wires in this location is minimal. To compensate for this, we used larger diameter wires (with a relatively high stiffness) for making a few apical stimulating contacts in the array, and thinner wires (with lower stiffness) for the basal stimulating contacts. In this way, an appropriate amount of stiffness is maintained throughout the length of the array. Results from an insertion study using human cadaver temporal bones demonstrated the full and nontraumatic insertion of our electrode array [25] .
In order to verify the biological safety of the implantable unit, we performed the cytotoxicity testing with eluate of the implantable unit. The result showed that there was no reaction of cells, indicating that the material used in the implantable unit should be well tolerated in vivo.
Long-term implantation tests based on the ISO 10993-6 standard were also performed. Six implantable units were transplanted in New Zealand white rabbits. No inflammation, hemorrhage, necrosis, or discoloration in the implanted region of the subjects has been observed 90 days following implantation, and these results indicates the gross biocompatibility of the implantable unit.
Speech perception tests with human patients to verify the effectiveness of the system are in progress, with the cooperation of the Center for Auditory Prosthesis Research at the Research Triangle Institute (RTI) in the United States. The data from the tests now in progress will be presented in a separate publication.
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